| 000 | 01119 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513194627.0 | ||
| 264 | 0 | _c19991208 | |
| 008 | 199912s 0 0 eng d | ||
| 022 | _a0094-6176 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDietrich, C P | |
| 245 | 0 | 0 |
_aStructural features and bleeding activity of commercial low molecular weight heparins: neutralization by ATP and protamine. _h[electronic resource] |
| 260 |
_bSeminars in thrombosis and hemostasis _c1999 |
||
| 300 |
_a43-50 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 |
_aHeparin, Low-Molecular-Weight _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aProtamines _xpharmacology |
| 700 | 1 | _aShinjo, S K | |
| 700 | 1 | _aMoraes, F A | |
| 700 | 1 | _aCastro, R A | |
| 700 | 1 | _aMendes, A | |
| 700 | 1 | _aGouvea, T C | |
| 700 | 1 | _aNader, H B | |
| 773 | 0 |
_tSeminars in thrombosis and hemostasis _gvol. 25 Suppl 3 _gp. 43-50 |
|
| 999 |
_c10506363 _d10506363 |
||